AMGEN INC (AMGN)
Clinical trial NCT06598306 updates: 1. completion date: 2030-03-27 → 2030-04-24 2. primary completion date: 2027-02-01 → 2027-03-03 3. enrollment: not set → 220 participants
Clinical trial NCT06598306 updates: 1. completion date: 2030-03-27 → 2030-04-24 2. primary completion date: 2027-02-01 → 2027-03-03 3. enrollment: not set → 220 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical